Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Akriti Seth
Alkem said it had a “mixed year”, registering growth in India and internationally despite setbacks that included a weak anti-infectives season and a recent Form 483 from the US Food and Drug Administration.
In a move to take its pipeline of biosimilar monoclonal antibodies global, Alvotech has struck a deal with Abdi Ibrahim that will give it localization advantages in Turkey.
After recent inspections, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has fully reinstated Good Manufacturing Practice (GMP) status for Bristol Laboratories’ UK manufacturing sites, enabling the firm to resume complete supply to the UK market.